日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

YY1 nitration participates in DbCM cardiomyocyte lipotoxicity by inhibiting ANXA3-induced microlipophagy

YY1硝化通过抑制ANXA3诱导的微脂自噬参与DbCM心肌细胞脂毒性

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2026.104085
Chai, Jiayin; Han, Lijie; Mo, Degang; Bai, Yunfei; Yang, Yiming; Ding, Yuqing; Chen, Shuai; Kong, Xiangning; Zhu, Xinyu; Xu, Lijia; Dai, Hongyan; Wang, Wen
YY1
细胞生物学
毒理研究
自噬
发表日期：2026
文献求助 收藏

Case Report: Mavacamten in mid-ventricular and apical hypertrophic cardiomyopathy-a case of targeted therapy beyond left ventricular outflow tract obstruction

病例报告：Mavacamten治疗中部室壁和心尖肥厚型心肌病——一例超越左心室流出道梗阻的靶向治疗病例

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1807582
Yang, Lijia; Dai, Hongyan; Rong, Yuanyuan
心血管
心肌病
发表日期：2026
文献求助 收藏

Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study

甘油三酯-葡萄糖相关指标与心血管-肾脏-代谢综合征0-3期人群全因死亡率和心血管死亡率之间的关联：一项队列研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02642-7
Zhang, Peng; Mo, Degang; Zeng, Wenhua; Dai, Hongyan
代谢综合征
代谢
发表日期：2025
文献求助 收藏

Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study

胆固醇、高密度脂蛋白和葡萄糖指数与甘油三酯-葡萄糖指数在预测心血管疾病风险方面的比较：一项队列研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02675-y
Mo, Degang; Zhang, Peng; Zhang, Miao; Dai, Hongyan; Guan, Jun
心血管疾病
心血管
代谢
发表日期：2025
文献求助 收藏

Association between the atherogenic index of plasma and incident hypertension across different blood pressure states: a national cohort study

血浆动脉粥样硬化指数与不同血压状态下新发高血压的关联：一项全国性队列研究

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02775-9
Mo, Degang; Zhang, Peng; Zhang, Miao; Dai, Hongyan; Wang, Guoan
心血管
动脉粥样硬化
高血压
发表日期：2025
文献求助 收藏

The association of non-HDL-C, NHHR, RC, and RCII with coronary artery stenosis severity in patients with acute coronary syndrome combined with cardiometabolic multimorbidity

非高密度脂蛋白胆固醇、NHHR、RC 和 RCII 与合并心血管代谢多病的急性冠脉综合征患者冠状动脉狭窄严重程度的相关性

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1701364
Zhang, Peng; Mo, Degang; Dong, Chao; Zeng, Wenhua; Li, Nuo; Wu, Jiani; Wang, Guoan; Dai, Hongyan
代谢
发表日期：2025
文献求助 收藏

Associations of the triglyceride-glucose index with short-term mortality in patients with cardiogenic shock: a cohort study

甘油三酯-葡萄糖指数与心源性休克患者短期死亡率的相关性：一项队列研究

期刊:Lipids in Health and Disease
影响因子:4.2
doi:10.1186/s12944-025-02548-z
Mo, Degang; Zhang, Peng; Wang, Mengmeng; Guan, Jun; Dai, Hongyan
发表日期：2025
文献求助 收藏

Serum Levels of TNFAIP3 and NLRP3 as Novel Biomarkers for Major Adverse Cardiovascular Events in Patients with Chronic Heart Failure: A Cohort Study

TNFAIP3 和 NLRP3 血清水平作为慢性心力衰竭患者主要不良心血管事件的新型生物标志物：一项队列研究

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S567963
Mo, Degang; Yang, Lijia; Zhang, Peng; Zhang, Miao; Guan, Jun; Wang, Guoan; Dai, Hongyan
AIP
心血管
LRP3
NLRP3
心力衰竭
发表日期：2025
文献求助 收藏

Insulin-like growth factor family and its impact on pulmonary arterial hypertension: a review

胰岛素样生长因子家族及其对肺动脉高压的影响：综述

期刊:Frontiers in Physiology
影响因子:3.4
doi:10.3389/fphys.2025.1679278
Li, Nuo; Mo, Degang; Dai, Hongyan
肺动脉高压
心血管
免疫/内分泌
发表日期：2025
文献求助 收藏

Case Report: Immune checkpoint inhibitor-associated pulmonary hypertension

病例报告：免疫检查点抑制剂相关性肺动脉高压

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2025.1705102
Yuan, Shanshan; Hu, Xueqing; Zhao, Yunquan; Dai, Hongyan
肺动脉高压
心血管
免疫/内分泌
发表日期：2025
文献求助 收藏